Idiopathic Thrombocytopenic Purpura
📧 Sign up to get email alerts when something new happens for Idiopathic Thrombocytopenic Purpura.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2018-07-17Clinical Trial Update: A Trial to Treat Patients With ITP Who Do Not Achieve a Durable Response to Rituxan Alone [Phase 2]
The Phase 2 trial evaluating treatment for Idiopathic Thrombocytopenic Purpura patients who do not have a durable response to Rituxan has be…
-
CLINICAL_TRIALS withdrawal · 2017-02-03Clinical Trial Update: Single Incision Versus Standard Laparoscopic Splenectomy [NA]
A clinical trial comparing single-incision versus standard laparoscopic splenectomy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-07-30Clinical Trial Update: MONICA-SC: A Study to Evaluate the Efficacy, Safety and Tolerability of Blisibimod (A-623) Administration in Subjects With ITP [Phase 2, Phase 3]
The MONICA-SC trial evaluating Blisibimod (A-623) for Immune Thrombocytopenic Purpura/Idiopathic Thrombocytopenic Purpura has been withdrawn…
-
CLINICAL_TRIALS withdrawal · 2014-07-28Clinical Trial Update: A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia. [Phase 2]
A Phase 2 clinical trial evaluating belimumab for chronic immune thrombocytopenia was withdrawn.